Semaglutide and tirzepatide are revolutionising weight loss globally — but the price gap between US and Chinese hospital pharmacies is enormous. Here is what you actually get for the difference.
In the United States, brand-name semaglutide (Wegovy) lists at USD 1,349 per month before insurance gymnastics. Tirzepatide (Mounjaro / Zepbound) is in the same range. At a Class A hospital pharmacy in Shanghai or Beijing, the same molecules — manufactured under regulated supply — typically cost USD 260–320 per month .
The Headline Number Most Patients See
In the United States, brand-name semaglutide (Wegovy) lists at USD 1,349 per month before insurance gymnastics. Tirzepatide (Mounjaro / Zepbound) is in the same range. At a Class A hospital pharmacy in Shanghai or Beijing, the same molecules — manufactured under regulated supply — typically cost USD 260–320 per month.
That gap is real. What it does not tell you is what you actually get for the price.
What "GLP-1 in China" Actually Includes
At a Class A international department, the standard pre-treatment workup before any GLP-1 prescription includes:
- Full endocrinology consultation (45–60 minutes)
- HbA1c, fasting insulin, lipid panel, ALT/AST, eGFR, TSH
- Thyroid ultrasound to screen for nodules (medullary thyroid carcinoma family history is a hard contraindication)
- BP, ECG, and cardiometabolic risk stratification
- A written titration plan with pharmacist-led GI side-effect coaching
This pre-treatment block typically costs USD 400–600 all-in. In US online-pharmacy channels, the equivalent workup is often skipped entirely — which is fine until it isn't.
Who Is Actually a Candidate?
International obesity guidelines (NICE NG246, ADA Standards of Care 2025, AACE) typically recommend GLP-1 therapy for adults with BMI ≥ 30, or BMI ≥ 27 with at least one obesity-related comorbidity (T2DM, hypertension, dyslipidaemia, OSA, MASLD). Take our free GLP-1 candidacy self-assessment for a structured 4-minute screen — it computes BMI, scores comorbidities, and gives you an evidence-based candidacy band.
The Trade-offs to Know
Chinese hospitals require an in-person evaluation before initial prescription. Subsequent prescriptions can be coordinated via telehealth with the prescribing physician. Insurance reimbursement from foreign insurers varies — Cigna Global, Bupa Global, and several Asian insurers cover Class A international department services, but you should pre-authorise.
For patients planning a multi-month therapeutic block, combining the workup with a short medical-tourism trip is often more economical than monthly US copays plus the lifetime workup gap. Maintenance refills can be shipped via licensed channels in many cases — discuss with the coordinator.
Bottom Line
The price arbitrage is genuine, but the value is bigger than the price tag: a structured workup, thyroid screening, and titration coaching matter for long-term success. Try the candidacy screener first — it tells you whether the trip is worth your time.
Sources: NICE NG246 obesity guideline; ADA Standards of Care in Diabetes 2025; AACE 2024 obesity practice statement; Class A hospital partner pricing data (2026).